Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Med Clin (Barc) ; 108(2): 54-61, 1997 Jan 18.
Article in Spanish | MEDLINE | ID: mdl-9064418

ABSTRACT

BACKGROUND: To provide epidemiological information on the extent of design drug use in Spain, the characteristics of users, and the types of substances consumed. MATERIALS AND METHODS: We analyzed two surveys on drug use carried out in 1993 and 1994 (one in the general population older than 15 years and the other in heroin and/or cocaine users who were not in treatment) as well as data on designer drug seizures confiscated by the General Police Headquarters and Ministry of Health laboratories. RESULTS: According to the general population survey, 4.5% of persons 16-40 years of age have tried design drugs at some time, 2.1% more than once, and 0.6% are current users. Design drug use is associated with age of 20-24 years and use of crack (odds ratio [OR] = 28.6), cannabis (OR = 12.5), cocaine (OR = 7.6) or heroin (OR = 3.8). According to the survey of heroin/cocaine users, 25% of cocaine users have used design drugs in the last 30 days, 11% of heroin users, and 18% of those who use both substances. Use is associated with the use of hallucinogens (OR = 4.8), non-use of the injected route (OR = 2), and having been interviewed in recreational areas (OR = 1.8). Police data reflect a stability in the quantities of amphetamines confiscated, a large increase in those of MDMA, and an absence of MDA and MDEA. Ministry of Health laboratories show an increase in confiscations of amphetamines and the presence of MDA, MDMA and MDEA in all years and areas studied, as well as the appearance of MBDB in 1994. CONCLUSIONS: The occasional use of different design drugs has spread to some degree among young people, varies considerably by geographic region, and is associated with the use of other legal and illegal substances, specially stimulants.


Subject(s)
Designer Drugs , Substance-Related Disorders/epidemiology , 3,4-Methylenedioxyamphetamine/analogs & derivatives , Adolescent , Adult , Cocaine , Female , Heroin , Humans , Male , N-Methyl-3,4-methylenedioxyamphetamine , Prevalence , Spain/epidemiology
2.
Drug Alcohol Depend ; 34(1): 45-57, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8174502

ABSTRACT

Trends and patterns of cocaine use in Spain are described with the aid of different information sources such as population surveys, the State Information System on Drug Abuse, and anthropological studies. In recent years the magnitude of cocaine supply indicators has increased greatly. High levels of last-month prevalence of cocaine use have been detected among the general population--consistently higher than those for heroin-- and cocaine consumption among heroin users has increased. Although the frequency of some health problems related to cocaine use--treatment admissions, hospital emergency admissions--has increased, it is still 30 times less than for heroin. Various hypotheses to explain these discrepancies are discussed.


Subject(s)
Cocaine , Cross-Cultural Comparison , Substance-Related Disorders/epidemiology , Adolescent , Adult , Aged , Child , Cocaine/supply & distribution , Cross-Sectional Studies , Diagnosis, Dual (Psychiatry) , Female , Heroin Dependence/epidemiology , Heroin Dependence/rehabilitation , Humans , Incidence , Male , Middle Aged , Population Surveillance , Spain/epidemiology , Substance-Related Disorders/rehabilitation
3.
Med Clin (Barc) ; 97(18): 703-5, 1991 Nov 23.
Article in Spanish | MEDLINE | ID: mdl-1770821

ABSTRACT

Myasthenia gravis (MG) and tricholeucemia (TL) produce an important immune alteration favoring the appearance of neoplastic and autoimmune disorders. The case of a 53 years old patient who developed type B TL 5 years after the diagnosis of MG is reported. Upon revision of the literature, 37 cases of association of MG and malignant hemopathies, fundamentally lymphoproliferative were found. In general, MG precedes the appearance of the neoplastic process. The autoimmunity and immunodeficiency characteristic of MG probably constitute the pathogenic mechanism leading to the appearance of the neoplastic process.


Subject(s)
Leukemia, Hairy Cell/diagnosis , Myasthenia Gravis/diagnosis , Bone Marrow/metabolism , Bone Marrow/ultrastructure , Humans , Immunohistochemistry , Leukemia, Hairy Cell/etiology , Male , Middle Aged , Myasthenia Gravis/complications , Spleen/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...